Early-onset hypertension during atezolizumab plus bevacizumab therapy predicts improved survival in unresectable HCC.

A study has found that a remote patient care program may effectively improve rates of blood pressure control in patients with hypertension.

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Abstract: Hypertension (HTN) is a significant global health crisis with rising prevalence, yet current management strategies often fall short. Traditional office-based care models often fall short in ...

If you have multiple blood pressure readings over 130/80 mm Hg, you might have hypertension, which can cause serious medical ...

Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents KELOWNA, BC / ACCESS Newswire / October 9, 2025 / Lexaria Bioscience ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies. Referred to as “Royalty Management Co” and ...

New study reveals nearly all cardiovascular disease cases are linked to modifiable risk factors like blood pressure, ...

Swalwell on shutdown possibility: ‘I don’t want to be a co-signee to this tyranny’ Military leaders voice concern over Hegseth’s new Pentagon strategy Texas Attorney General Paxton weighs in on Bad ...